These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study. Marschall J; Fejer G; Lempe P; Prochazkova L; Kuchar M; Hajkova K; van Elk M J Psychopharmacol; 2022 Jan; 36(1):97-113. PubMed ID: 34915762 [TBL] [Abstract][Full Text] [Related]
13. Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders. Lea T; Amada N; Jungaberle H; Schecke H; Scherbaum N; Klein M Psychopharmacology (Berl); 2020 May; 237(5):1521-1532. PubMed ID: 32043165 [TBL] [Abstract][Full Text] [Related]
14. Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration. Fadiman J; Korb S J Psychoactive Drugs; 2019; 51(2):118-122. PubMed ID: 30925850 [TBL] [Abstract][Full Text] [Related]
15. Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study. Hutten NRPW; Mason NL; Dolder PC; Theunissen EL; Holze F; Liechti ME; Feilding A; Ramaekers JG; Kuypers KPC Eur Neuropsychopharmacol; 2020 Dec; 41():81-91. PubMed ID: 33082016 [TBL] [Abstract][Full Text] [Related]
16. Microdosing with classical psychedelics: Research trajectories and practical considerations. Wong A; Raz A Transcult Psychiatry; 2022 Oct; 59(5):675-690. PubMed ID: 36317302 [TBL] [Abstract][Full Text] [Related]